Home

arrow iconNewsarrow iconarrow icon

FERSOG - Ghana Must Recognize Infertility as Disease

FERSOG - Ghana Must Recognize Infertility as Disease

The Fertility Society of Ghana has urged the government to officially recognize infertility as a disease and include basic fertility services in the National Health Insurance Scheme during its eighth Annual General meeting, held in Tema.

By FertilityIn

09 Dec 2025

3 min read

The Fertility Society of Ghana

The Fertility Society of Ghana

The Fertility Society of Ghana (FERSOG) has intensified calls for the government to officially recognize infertility as a disease, aligning with international health standards set by the World Health Organization (WHO). The society made this appeal during its eighth Annual General Meeting and Scientific Conference, which took place on October 16-18, 2025.



Dr. Rudolph Kantum Adageba, President of FERSOG, described the current healthcare arrangement where couples pay out-of-pocket for infertility services as "unfair, discriminatory and unjust." He emphasized that infertility must be viewed as a public health concern rather than a private financial burden.​



The World Health Organization has defined infertility as a disease and a major disability. As a country, we must see it as such, just as we see other diseases, said Dr. Adageba at the conference, which brought together clinicians, embryologists, nurses, and policymakers under the theme "Reducing the Burden of Infertility in Ghana: Awareness, Preservation, and Infertility Prevention."



FERSOG has submitted a position paper to the National Health Insurance Authority (NHIA) and other stakeholders, advocating for the inclusion of basic infertility services in the National Health Insurance Scheme (NHIS). These services include clinical consultations, semen analysis, hormone profiling, pelvic ultrasound, and intrauterine insemination (IUI). Dr. Adageba noted that the society would continue engaging with the NHIA to establish realistic fees for these services.​



The recognition of infertility as a disease carries significant implications for Ghana's healthcare system. Research indicates that infertility affects approximately 11.8% of women and 15.8% of men in Ghana, with affected couples facing devastating biomedical, psychological, and sociocultural consequences. In Ghanaian society, where children are expected to maintain family lineage and ensure marital stability, the inability to conceive often results in social stigma, discrimination, and psychological distress, particularly for women.​



Currently, Ghana has 22 assisted reproductive technology (ART) centers located in only three of the country's 16 regions, primarily serving middle- and upper-class populations in urban areas. The average cost of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) is approximately 50,000 Ghana Cedis (USD 3,400), far beyond the reach of most Ghanaians, whose national daily minimum wage stands at 19.97 Ghana Cedis (USD 1.4).​



Prof. Dr. Titus Kofi Beyuo, Member of Parliament for Lambussie and member of the Parliamentary Select Committee on Health, announced that the Assisted Reproductive Technologies Bill is at an advanced stage. The Minister of Health is currently working on two key legislative documents: the ART Bill and the Organ Donation and Transplant Medicine Bill. The minister is very committed to passing this bill, Prof. Beyuo assured attendees, encouraging fertility professionals to collaborate more closely with Parliament in their advocacy efforts.​



The conference highlighted that recognizing infertility as a disease would pave the way for regulatory frameworks, standardized care protocols, and financial support through the NHIS. This move would address the current situation where 70.2% of women seeking ART treatment withdraw due to prohibitive costs, and 35.57% discontinue due to partner unavailability.​



FERSOG's advocacy represents a critical step toward achieving reproductive justice in Ghana. By securing disease status for infertility and integrating treatment into the national health insurance scheme, the government could significantly reduce the burden on affected couples and ensure equitable access to fertility care across all socioeconomic classes.

45 views

Share

FertilityIn

Send Enquiry for this Story

Related Articles

Luna and Kindbody Partner to Advance Data-Driven Intelligence in Fertility Care

Luna and Kindbody Partner to Advance Data-Driven Intelligence in Fertility Care

Luna and Kindbody are redefining Intelligence in Fertility Care through a strategic partnership that integrates wearable biomarker tracking into clinical pathways. By capturing real-time physiological data, the collaboration enables personalised insights, enhances decision-making, and creates a more connected, data-driven fertility journey for patients and care providers alike.

ART

1 min read

Sapyen and Avenues Launch At-Home Fertility Diagnostics in UK

Sapyen and Avenues Launch At-Home Fertility Diagnostics in UK

Sapyen and Avenues launch at-home fertility diagnostics, introducing a couple-first testing model in the UK. By integrating semen analysis and AMH testing into early care, this approach reduces clinic visits, accelerates diagnosis, and ensures balanced fertility evaluation, transforming how patients begin their reproductive health journey.

ART

1 min read

Nexpring Health Invests in Technology for PCOS-Related Infertility

Nexpring Health Invests in Technology for PCOS-Related Infertility

Nexpring Health has invested in May Health to accelerate the development of the Anavi™ System, a novel device designed to treat PCOS-Related Infertility. The technology aims to restore ovulation through a single office-based procedure, expanding treatment options for millions of women affected by polycystic ovary syndrome.

ART

1 min read

INVO Fertility to Introduce Time-Lapse Incubation Technology to Enhance IVF Success Rates and Patient Outcomes

INVO Fertility to Introduce Time-Lapse Incubation Technology to Enhance IVF Success Rates and Patient Outcomes

INVO Fertility would be introducing time-lapse incubation technology at its Wisconsin clinic, hence offering high-quality lab care, creative patient solutions, and advanced embryo monitoring for improved fertility results.

ART

1 min read

Industry Leaders to Transform Fertility Care in the U.S. Through Groundbreaking Partnership Making Treatment More Accessible

Industry Leaders to Transform Fertility Care in the U.S. Through Groundbreaking Partnership Making Treatment More Accessible

Costco, Sesame, and IVI RMA North America have announced strategic partnership to alter fertility care in the U.S. by removing biggest obstacles to care including high costs and limited access.

ART

1 min read

Carea Launches the Trying to Conceive - IVF/IUI Mode to Empower Women with Seamless and Reliable Digital Support

Carea Launches the Trying to Conceive - IVF/IUI Mode to Empower Women with Seamless and Reliable Digital Support

Carea has launched its Trying to Conceive - IVF/IUI mode to help women undergoing intricate fertility treatment with risks of inconsistent clinic continuity through continuous tracking and expert guidance.

ART

1 min read

Minnesota Bill for Infertility Treatments Expands Insurance Coverage by 2027

Minnesota Bill for Infertility Treatments Expands Insurance Coverage by 2027

The Minnesota bill for infertility treatments mandates comprehensive insurance coverage for diagnosis, IVF, and fertility preservation across public and private health plans. Set for implementation in 2027, the legislation expands access, modernises infertility definitions, and ensures cost-sharing protections to make reproductive healthcare more equitable.

ART

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address